Core Viewpoint - The announcement indicates a strategic collaboration between China Dental Industry and Bio-Hui Biotechnology to enhance their business operations in the healthcare sector, particularly in the Greater Bay Area [1] Group 1: Strategic Collaboration - China Digital Health, a wholly-owned subsidiary of China Dental Industry, has signed a memorandum of understanding with Bio-Hui Biotechnology to establish a joint venture [1] - The joint venture aims to form qualified medical and biotechnology teams to promote clinical treatment services in hospitals within the Greater Bay Area [1] Group 2: Business Diversification - The board of directors believes that this memorandum marks a new phase for the group in entering the medical biotechnology field and provides opportunities for diversified business development [1] - Through this strategic partnership, the group aims to leverage its connections in the Greater Bay Area to broaden its revenue base and enhance overall competitiveness [1]

Core Viewpoint - The announcement indicates a strategic collaboration between China Oral Industry and BioHui Biotechnology to enhance their business operations in the medical biotechnology sector, marking a new phase for the company [1] Group 1: Strategic Collaboration - China Digital Health Group, a wholly-owned subsidiary of China Oral Industry, has signed a memorandum of understanding with BioHui Biotechnology to establish a joint venture [1] - The collaboration aims to form qualified medical and biotechnology teams to promote clinical treatment services in the Greater Bay Area hospitals [1] Group 2: Company Growth and Diversification - The board believes that this memorandum signifies a new stage for the company’s entry into the medical biotechnology field and presents opportunities for diversified business development [1] - Through the strategic partnership with BioHui, the company aims to leverage its connections in the Greater Bay Area to broaden its revenue base and enhance overall competitiveness [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 自願公告 諒解備忘錄 本 公 告 乃 中 國 口 腔 產 業 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）自 願 刊 發，旨 在 向 本 公 司 股 東（「股 東」）及 潛 在 投 資 者 提 供 有 關 本 集 團 最 新 業 務 發 展 的 最 新 資 料。 諒解備忘錄 本 公 司 董 事（「董 事」）董 事 會（「董事會」）欣 然 宣 布，於 二 零 二 六 年 一 月 十 二 日，本 公 司 間 接 全 資 附 屬 公 司 中 國 數 字 健 康 集 團 有 限 公 司（「中國數字健康」）與 博 惠 生 技 股 份 有 ...

Core Viewpoint - The company has agreed to acquire an 86.22% stake in Hebei Chenxiang Power Sales for RMB 135 million, which will allow it to consolidate the financial performance of the target group into its own financial statements [1][2] Group 1: Acquisition Details - The acquisition agreement was signed on January 12, 2026, and upon completion, the target group will become a subsidiary of the company [1] - The target group primarily engages in electricity business, which is crucial for the company's manufacturing operations [1] Group 2: Strategic Importance - The company has entered into a high-voltage electricity supply contract with Chenteng Power Sales, ensuring reliable electricity supply from November 1, 2023, to October 31, 2026 [1] - By acquiring control over the authorized power supplier, the company aims to enhance the stability and continuity of its electricity supply, optimizing operational and compliance efficiency [2] Group 3: Financial Implications - The acquisition is expected to diversify and enrich the company's revenue sources as the target group's electricity trading, supply, and construction businesses develop [2] - Given the stable and urgent demand for electricity, the company anticipates improved financial flexibility from the acquisition's synergies [2]

（於開曼群島註冊成立之有限公司） （股份代號：8007） 自願公告 有關可能收購事項的諒解備忘錄 本公告乃環球戰略集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）自願作出， 旨在向本公司股東（「股東」）及潛在投資者提供本集團最新業務進展的資料。 諒解備忘錄 本公司董事（「董事」）會（「董事會」）欣然宣佈，於二零二六年一月十二日（交易時段後）， 本公司與江西洽田清潔能源有限公司（「潛在賣方」）訂立一份不具法律約束力的諒解備 忘錄（「諒解備忘錄」）。根據諒解備忘錄，本集團有意收購及潛在賣方有意出售宜昌市巨 人加油站有限公司（「目標公司」）不少於51%的股權（「可能收購事項」）。倘可能收購事 項得以落實，其可能會構成香港聯合交易所有限公司GEM證券上市規則（「GEM上市規 則」）所指本公司的須予公佈的交易。 1 諒解備忘錄的主要條款 香港交易及結算所有限公司及聯交所對本公告之內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 GLOBAL STRATEGIC GROUP LIMITED 環球戰略集團有限公司 環 ...

Core Viewpoint - New Morning Power (01148.HK) announced a strategic acquisition plan to acquire 53% of AVIC Lantian Equipment Manufacturing Co., Ltd. for up to 147 million yuan, with an additional investment of 5 million USD (approximately 36 million yuan), totaling about 183 million yuan, aiming to enhance its market presence in non-road vehicles [1][8] Group 1: Acquisition Details - The acquisition will result in New Morning Power holding approximately 60% of AVIC Lantian, making it an indirect non-wholly-owned subsidiary [1][8] - The transaction is subject to several conditions, including due diligence completion and internal approvals, with a final deadline of June 30, 2026 [12] Group 2: Financial Concerns - AVIC Lantian reported net losses of 18.872 million yuan and 23.413 million yuan for 2023 and 2024, respectively, raising concerns about its operational capabilities [2][9] - The acquisition lacks any performance commitment from the original shareholders, meaning New Morning Power will bear the risk of turning around AVIC Lantian's financial performance [2][9] Group 3: Strategic Rationale - The acquisition aims to diversify New Morning Power's business, which primarily focuses on passenger and light commercial vehicle engines, by integrating AVIC Lantian's complementary product lines in special equipment and industrial robotics [3][10] - This move aligns with New Morning Power's long-term strategy to transition towards new energy power systems, especially as the traditional engine market slows down [3][10] Group 4: Market Challenges - The transaction faces three main challenges: the pressure to achieve profitability for AVIC Lantian, integration risks due to geographical and cultural differences, and the cyclical nature of the special vehicle and mining machinery market [4][11] - New Morning Power's revenue growth of 13.88% and 7.06% for 2024 and the first half of 2025 is overshadowed by declining net profits of 7.06% and 25.46%, indicating potential financial strain [4][11] Group 5: Government Support - The collaboration is viewed as a model for "Sichuan-Jin Industry Collaboration," with local government support expected to facilitate the integration process [3][10]

Ceragon Networks (NasdaqGS:CRNT) Business Update Summary Company Overview - **Company**: Ceragon Networks - **Date of Update**: January 08, 2026 - **Context**: The call provided insights into Ceragon's preliminary Q4 revenue and outlook for 2026, addressing recent business developments and strategic initiatives. Key Points Industry and Market Context - **Forward-Looking Statements**: The discussion included forward-looking statements regarding financial performance, business outlook, and associated risks, including global economic conditions and supply chain challenges [2][3] - **Customer Dynamics**: A significant North American customer shifted deliveries from Q4 2025 to 2026, impacting revenue expectations for Q4 [4][5] Financial Performance - **Q4 Revenue Expectation**: Projected revenue for Q4 is between $81 million and $83 million, influenced by the timing shift of deliveries [4] - **2026 Revenue Guidance**: Expected revenue for 2026 is projected to be between $355 million and $385 million, factoring in delayed deliveries and strong backlog in North America [7] - **India Revenue Run Rate**: Starting 2026 with an annual revenue run rate of approximately $100 million, primarily from two main customers, with potential for incremental growth [7][8] Business Strategy and Growth - **Diversification Strategy**: Ceragon aims to reduce customer concentration by expanding its presence in private networks and acquiring new customers, with over 30 new customers added in 2025, 75% of which are private network customers [6] - **Product Development**: Plans to launch four new products in 2026, driven by market demand, to enhance competitive positioning [10] - **Managed Services**: Transitioning towards business models like managed services and connectivity as a service to smooth revenue recognition and reduce volatility [33] Operational Insights - **Gross Margin Improvement**: Anticipated improvement of approximately one percentage point in gross margin for 2026, driven by a better revenue mix and cost reduction initiatives [9] - **Currency Impact**: The Israeli Shekel exchange rate is expected to create a $5 million headwind for the year, affecting operating expenses [9][18] Customer and Project Management - **Backlog Growth**: North American backlog nearly doubled compared to the end of 2024, indicating strong demand and optimism for 2026 [5][26] - **Project Execution**: The shift in delivery timing was attributed to internal decisions by the customer rather than Ceragon's performance, indicating a stable relationship with key clients [30] Competitive Landscape - **Market Position**: Initial signs of positive developments in the competitive landscape, although specific details were not disclosed [35] Additional Considerations - **Investment in R&D**: Continued investment in research and development and sales and marketing to capitalize on market momentum [11] - **Capital Allocation Strategy**: Ongoing evaluation of capital allocation to balance investments in growth and returns to shareholders [12] This summary encapsulates the critical insights from Ceragon Networks' business update, highlighting the company's financial outlook, strategic initiatives, and market positioning.

Core Viewpoint - Weigao Blood Purification plans to acquire 100% equity of Weigao Puri Pharmaceutical Packaging for an assessed value of 8.511 billion yuan, marking a significant asset restructuring and expanding its business into pharmaceutical packaging [2] Group 1: Acquisition Details - The acquisition will be fully paid through the issuance of shares, with Weigao Co. and its concerted parties increasing their stake in Weigao Blood Purification to 84.36%, maintaining absolute control [2] - Weigao Puri, established in 2018, specializes in pre-filled drug delivery systems and automatic safety drug delivery systems, aiming to provide comprehensive drug delivery solutions for global biopharmaceutical companies [2] Group 2: Financial Performance - As of June 30, 2025, Weigao Puri reported total assets of 3.425 billion yuan, total liabilities of 730 million yuan, and equity of 2.695 billion yuan, with a revenue of 939 million yuan and a net profit of 327 million yuan in the first half of 2025, indicating strong profitability [2] Group 3: Market Position - Weigao Puri has broken the overseas technology monopoly and holds a leading position in the domestic pre-filled product market, with over 50% market share from 2022 to 2024, ranking first domestically and among the top five internationally [3] Group 4: Strategic Rationale - The acquisition aims to diversify business operations and achieve technological synergy, allowing Weigao Blood Purification to leverage Weigao Puri's expertise in pharmaceutical packaging to expand its product line and reduce risks associated with a single business area [4] - The growing biopharmaceutical industry in China, projected to reach 534.8 billion yuan in 2024 and 1.13 trillion yuan by 2032, presents significant opportunities for both pharmaceutical packaging and upstream biopharmaceutical materials [4]

Core Viewpoint - Songyang Resources is divesting its controlling stake in Songyang Lottery (Beijing) Management Co., Ltd. due to the lottery business not aligning with the company's development strategy, despite previous interest in the sector [1][4]. Group 1: Company Overview - Songyang Resources, based in Shantou, Guangdong, operates in the environmental recycled paper industry and has a market capitalization of 4.3 billion yuan [1]. - The company entered the lottery industry two years ago, which initially attracted significant capital interest and led to a surge in stock price [1]. Group 2: Business Operations - Songyang Lottery, the main operating company for Songyang Resources' lottery business, opened two physical lottery stores in Beijing in 2024 [2]. - The company plans to transfer its 51% stake in Songyang Lottery to individual Zhao Xiangyue for 1 yuan, with Zhao responsible for fulfilling the corresponding capital contribution obligations [2]. Group 3: Financial Performance - Songyang Lottery reported a revenue of 96,000 yuan and a loss of 1.5092 million yuan in 2024, while the first three quarters of this year showed a revenue of 198,200 yuan and a loss of 611,300 yuan [3]. - In contrast, Songyang Resources reported a revenue of 314 million yuan and a loss of over 86.7 million yuan in the first three quarters of this year [3]. Group 4: Strategic Implications - The divestment of Songyang Lottery is seen as a move to optimize the company's business structure and focus on its core operations, potentially indicating a strategic shift away from the lottery sector [2][4]. - The company has also invested in Jinling Lottery Technology Co., which is involved in video electronic lottery services, but this venture is still in its early stages due to regulatory delays [4].

Core Viewpoint - The company, Pinchuang Holdings (08066.HK), has entered into a transfer agreement with Nanjing Qichuang, transferring its 30% investment rights and related responsibilities for a television production for a consideration of RMB 24.2 million [1] Group 1: Investment Details - The investment was originally part of the company's strategy to diversify into the advertising, media, and entertainment sectors, with an initial investment commitment of RMB 24 million for the television production [1] - The production was directed by Wang Deqing and produced by Zhang Jian, featuring actors Zhang Ming'en and Feng Yue, with an expected release in 2020 [1] Group 2: Production Delays - The production faced significant delays due to the COVID-19 outbreak, with completion only achieved in 2023 [1] - Additional time is required for negotiations and establishing sales contracts that meet expected revenue targets, leading to a revised release date projected for mid-2026 [1] - Revenue sharing from the production is now expected to be received by the third quarter of 2026 [1]